Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.
Vlassara, Helen; Cai, Weijing; Tripp, Elizabeth; Pyzik, Renata; Yee, Kalle; Goldberg, Laurie; Tansman, Laurie; Chen, Xue; Mani, Venkatesh; Fayad, Zahi A; Nadkarni, Girish N; Striker, Gary E; He, John C; Uribarri, Jaime.
; 59(10): 2181-92, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27468708
Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.
Evolution of resistance to a last-resort antibiotic in Staphylococcus aureus via bacterial competition.
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial.
Reverse GWAS: Using genetics to identify and model phenotypic subtypes.
A Novel Dipeptidyl Peptidase IV Inhibitory Tea Peptide Improves Pancreatic ß-Cell Function and Reduces α-Cell Proliferation in Streptozotocin-Induced Diabetic Mice.
Statins for children with familial hypercholesterolemia.
Nucleotide Excision Repair and Transcriptional Regulation: TFIIH and Beyond.